Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Guzelant G., Ucar D., Esatoglu S. N., Hatemi G., Ozyazgan Y., Yurdakul S., ...More

Clinical and experimental rheumatology, no.6, pp.86-89, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: Issue: 6
  • Publication Date: 2017
  • Journal Name: Clinical and experimental rheumatology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.86-89
  • Istanbul University Affiliated: Yes

Abstract

Objective. The prognosis of uveitis in Behcet's syndrome (BS) has improved over decades. Whether this is related to the use of more aggressive management strategies is not known.